Prof. Keqing Shi | Pathology | Best Researcher Award
Director at The First Affiliated Hospital of Wenzhou Medical University, China
Dr. Shi Keqing is a distinguished professor, deputy chief physician, and doctoral supervisor with expertise in mechanobiology and cancer research. Over the past several years, he has made significant contributions to translational medicine, aiming to address pressing clinical challenges through innovative research. He has authored multiple high-impact publications in leading international journals and holds authorized invention patents, showcasing his strong scientific productivity and innovation. In addition to his academic achievements, he has successfully led major research projects supported by national and provincial foundations, demonstrating strong leadership and commitment to advancing medical science. He has also played a key role in establishing a clinic-based biomechanics platform, bringing together a multidisciplinary research team to bridge clinical applications with scientific exploration. His editorial responsibilities further highlight his role in shaping academic discourse, while his active involvement in talent development reflects his dedication to nurturing the next generation of researchers.
Professional Profile
Scopus Profile | ORCID Profile
Education
Dr. Shi Keqing pursued rigorous medical training, culminating in an MD degree, which laid a solid foundation for his career in clinical medicine and scientific research. His academic journey combined both clinical expertise and research excellence, enabling him to bridge the gap between medical practice and scientific inquiry. Through his education, he acquired strong theoretical knowledge in biology, medicine, and cancer research, complemented by practical training in advanced clinical methodologies. His exposure to diverse academic environments provided him with the analytical and problem-solving skills necessary to address complex medical challenges. This solid educational background allowed him to progress into specialized fields such as mechanobiology and translational medicine. With a commitment to academic growth, he pursued further learning and research opportunities, shaping his career as both a clinician and a scientist. His educational path reflects a balance of clinical medicine and innovative biomedical research, preparing him to contribute significantly to multidisciplinary advancements.
Professional Experience
Dr. Shi Keqing has established a remarkable professional career as a professor, deputy chief physician, and doctoral supervisor, integrating both academic and clinical responsibilities. His professional journey includes leading multiple research projects funded by the National Natural Science Foundation, provincial research programs, and ministry-level initiatives, reflecting his expertise in project management and scientific innovation. In addition to his research contributions, he has played a significant role in mentoring doctoral students and building a multidisciplinary team dedicated to translational medicine. He has also contributed to the development of a clinic-based biomechanics platform, which serves as a hub for collaborative studies between clinicians and researchers. Beyond his institutional responsibilities, Dr. Shi serves as a member of the editorial board of the Journal of Clinical and Translational Hepatology, actively contributing to academic publishing and peer review. His combined clinical practice and academic leadership underline his commitment to advancing both patient care and scientific discovery.
Research Interest
Dr. Shi Keqing’s research interests focus on mechanobiology and cancer, with an emphasis on developing translational strategies that connect fundamental science with clinical applications. His work explores how mechanical forces and biological processes interact in cancer development and progression, aiming to uncover new therapeutic approaches for improving patient outcomes. In addition to cancer research, he is interested in biomaterials, tissue repair, immunotherapy, and advanced diagnostic technologies, reflecting the multidisciplinary nature of his scientific approach. He has contributed to the development of innovative biomaterials for wound healing, novel drug delivery platforms, and advanced biosensors for cancer detection. His research also extends to exploring genetic and molecular mechanisms that influence immune responses and tumor microenvironments. By combining experimental studies with clinical applications, his research contributes to the creation of practical solutions to pressing medical challenges. His overarching goal is to address critical health issues by integrating scientific discovery with clinical innovation.
Award and Honor
Dr. Shi Keqing has been widely recognized for his contributions to medical research and has received numerous honors and distinctions throughout his career. He has been selected as a high-level top talent among leading academics in Zhejiang Province and has been included in the Academician Pair Youth Talent Training Program, demonstrating recognition of his leadership potential in academia. He has also been named among the young top talents of the Wenzhou Ou Yue Yingtalent Plan and the second level of the Wenzhou 551 Talent Project, reflecting both regional and institutional acknowledgment of his scientific achievements. His role as an editorial board member of the Journal of Clinical and Translational Hepatology highlights his influence in the international academic community. These awards and honors emphasize not only his research excellence but also his dedication to advancing clinical applications through translational medicine. They underscore his leadership, vision, and sustained contributions to biomedical research.
Research Skill
Dr. Shi Keqing has developed advanced research skills that encompass a wide range of techniques in mechanobiology, cancer biology, and translational medicine. He is skilled in integrating molecular biology, cell biology, and biomaterials research to design innovative therapeutic strategies. His expertise includes developing bio-inspired materials for tissue repair, exploring immune modulation mechanisms, and advancing cancer diagnostics through biomarker detection and nanotechnology. He has demonstrated strong proficiency in leading clinical and laboratory collaborations, establishing platforms that bring together multidisciplinary teams to tackle complex medical problems. His research skills extend to managing large-scale funded projects, authoring high-impact scientific publications, and guiding doctoral candidates in their academic growth. Additionally, he has expertise in applying computational approaches to medical imaging and pathology analysis, which strengthens his work in precision medicine. His ability to connect laboratory research with clinical translation demonstrates a holistic skill set that supports both scientific innovation and patient-centered outcomes.
Publications Top Notes
Title: A dynamically phase-adaptive regulating hydrogel promotes ultrafast anti-fibrotic wound healing
Year: 2025
Citation: 13
Title: Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress
Year: 2025
Citation: 13
Title: Piezo1-Mediated Ferroptosis Delays Wound Healing in Aging Mice by Regulating the Transcriptional Activity of SLC7A11 through Activating Transcription Factor 3
Year: 2025
Citation: 2
Title: Modulation of Macrophage ferroptosis under the guide of infrared thermography promotes the healing of pressure injuries
Year: 2025
Title: Natural, safety immunomodulatory derivatives of lactobacillus biofilms promote diabetic wound healing by metabolically regulating macrophage phenotype and alleviating local inflammation
Year: 2025
Title: Dental Pulp Stem Cell Lysate-Based Hydrogel Improves Diabetic Wound Healing via the Regulation of Anti-Inflammatory Macrophages and Keratinocytes
Year: 2024
Citation: 2
Title: Nanoparticles Fueled by Enzyme for the Treatment of Hyperlipidemic Acute Pancreatitis
Year: 2024
Citation: 2
Title: ACURAT: Advancing tuberculosis detection through assembled PCR & CRISPR for ultra-sensitive Rifampin-resistant analysis testing
Year: 2024
Citation: 3
Title: Sequential Regulation of Local Reactive Oxygen Species by Ir@Cu/Zn-MOF Nanoparticles for Promoting Infected Wound Healing
Year: 2024
Citation: 3
Title: Enteral nutrition in the management of acute pancreatitis: Modulates gut microbiome and alleviates inflammation
Year: 2024
Citation: 2
Conclusion
Overall, Dr. Shi Keqing stands out as a highly deserving candidate for the Best Researcher Award due to his impactful contributions at the intersection of mechanobiology and cancer research, his leadership in multidisciplinary translational medicine, and his dedication to solving clinical problems through innovative science. His impressive publication record, funded projects, and professional recognition underline his excellence, while his future potential lies in expanding his global collaborations and leadership roles, ensuring continued advancement of both research and clinical applications for the benefit of society.